Valuation: Q-linea AB

Market Cap 323M 33.52M 29.29M 27.03M 24.91M 46.96M 3.23B 48M 127M 1.58B 126M 123M 5.44B P/E 2024
-0.37x
P/E 2025 -0.91x
Enterprise Value 70.82M 7.35M 6.42M 5.92M 5.46M 10.29M 708M 10.52M 27.85M 347M 27.59M 26.99M 1.19B EV / Sales 2024
49.8x
EV / Sales 2025 14.4x
Free-Float
86.04%
Yield 2024 *
-
Yield 2025 -
1 day-0.29%
1 week-1.45%
1 month-1.73%
3 months-20.70%
6 months-36.96%
Current year-31.64%
1 week 16.55
Extreme 16.55
17.55
1 month 16.1
Extreme 16.1
19.2
Current year 14.55
Extreme 14.55
38.42
1 year 14.55
Extreme 14.55
64
3 years 14.55
Extreme 14.55
10,300
5 years 14.55
Extreme 14.55
164,000
10 years 14.55
Extreme 14.55
187,500
Manager TitleAgeSince
Chief Executive Officer 48 2025-10-18
Director of Finance/CFO 57 2026-06-14
Director of Finance/CFO 62 2017-12-31
Director TitleAgeSince
Chairman 70 2025-06-25
Chairman 64 2017-12-31
Director/Board Member 62 2026-05-26
Date Insider Type Main position Quantity % Market Cap.
11/21/25 Buy

Chairman

4,000 0.0207%
11/12/25 Fiscal year

Chief Executive Officer

35,400 0.1833%
11/11/25 Buy 3,000 0.0155%
Change 5-day change 1-year change 3-year change Capi.($)
-0.29%-1.45%-71.58%-99.43% 33.52M
-1.46%+0.58%+18.67%-22.19% 17.27B
-6.27%-7.01%-0.84%+86.72% 1.57B
-4.71%-4.87%-31.71%-79.21% 1.19B
-1.34%-5.93%-37.82%+13.91% 999M
-4.06%+2.84%-28.35%-52.18% 644M
-7.46%-4.05%-40.62%-56.91% 532M
-1.95%-4.52%+45.72%-53.63% 445M
-1.26%+0.64%-54.33%-58.41% 382M
+7.76%+6.36%-19.65%-21.95% 364M
Average -2.10%-1.35%-22.05%-34.33% 2.34B
Weighted average by Cap. -2.01%-0.35%+8.37%-19.16%

Financials

2024 2025
Net sales 4.14M 429K 375K 346K 319K 602K 41.35M 615K 1.63M 20.25M 1.61M 1.58M 69.72M 15.28M 1.59M 1.39M 1.28M 1.18M 2.22M 153M 2.27M 6.01M 74.79M 5.96M 5.82M 257M
Net income -217M -22.5M -19.66M -18.14M -16.72M -31.52M -2.17B -32.22M -85.3M -1.06B -84.5M -82.65M -3.65B -182M -18.93M -16.55M -15.27M -14.07M -26.52M -1.82B -27.11M -71.78M -893M -71.1M -69.54M -3.07B
Net Debt 126M 13.02M 11.38M 10.5M 9.68M 18.25M 1.25B 18.65M 49.38M 614M 48.91M 47.84M 2.11B -252M -26.17M -22.87M -21.11M -19.45M -36.67M -2.52B -37.48M -99.22M -1.23B -98.29M -96.13M -4.25B
Logo Q-linea AB
Q linea AB is a Sweden-based medical technology company. The Company develops and manufactures in-vitro diagnostic (IVD) solutions for infectious diseases. The Company's core product candidate is ASTar, a fully-automated instrument for Antibiotic Susceptibility Testing (AST). It measures bacteria's antimicrobial susceptibility using the disposables developed by the Company. It is able to provide a susceptibility profile within three to six hours directly from a positive blood culture, which enables early administration of antibiotics specifically targeting the disease-causing pathogen. Its main application is the identification of sepsis in hospital patients and the product is aimed primarily at hospital laboratories.
Employees
70
Date Price Change Volume
26-07-17 SEK 17.05 -0.29% 234
26-07-16 SEK 17.10 +2.09% 3,876
26-07-15 SEK 16.75 +0.30% 2,746
26-07-14 SEK 16.70 -1.76% 2,237
26-07-13 SEK 17.00 -1.73% 8,644

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. QLINEA Stock